Genomic Analysis of a New MRSA Strain in Cystic Fibrosis Patients
Author Information
Author(s): Rolain Jean-Marc, François Patrice, Hernandez David, Bittar Fadi, Richet Hervé, Fournous Ghislain, Mattenberger Yves, Bosdure Emmanuelle, Stremler Nathalie, Dubus Jean-Christophe, Sarles Jacques, Reynaud-Gaubert Martine, Boniface Stephanie, Schrenzel Jacques, Raoult Didier
Primary Institution: URMITE CNRS-IRD UMR 6236, Faculté de Médecine et de Pharmacie, Université de la Méditerranée, Marseille, France
Hypothesis
The study aims to analyze the genomic features of a new multiresistant Staphylococcus aureus strain spreading among cystic fibrosis patients.
Conclusion
The study demonstrated the emergence and spread of a new MRSA isolate in cystic fibrosis patients, likely selected by antibiotic pressure.
Supporting Evidence
- CF-Marseille is multidrug resistant and has a unique growth phenotype.
- Phylogenetic analysis showed CF-Marseille is closely related to strain Mu50.
- Presence of a new antibiotic inducible bacteriophage was identified.
- High antibiotic pressure in cystic fibrosis patients may promote the spread of this strain.
Takeaway
Researchers found a new type of superbug in cystic fibrosis patients that can resist many antibiotics, which is concerning because it can spread easily.
Methodology
The study involved genome sequencing of a representative isolate and retrospective epidemiological analysis of S. aureus strains from cystic fibrosis patients.
Potential Biases
Potential bias in the selection of strains for analysis and the retrospective nature of the epidemiological data.
Limitations
The study may not account for all genetic variations present in other strains of S. aureus.
Participant Demographics
The study included 108 adults and 98 children with cystic fibrosis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website